NEUROSURGICAL PERSPECTIVES ON CEREBRAL MUCORMYCOSIS IN THE POST-COVID-19 ERA: A RETROSPECTIVE ANALYSIS

Abstract

Introduction: There has been a recent surge in cerebral mucormycosis cases among COVID-19 patients due to several factors, including compromised barrier defense mechanisms and the administration of immunosuppressive drugs such as steroids for COVID-19 treatment. The primary aim of this study was to delineate the pattern of cerebral mucormycosis involvement and identify associated factors in COVID-19 patients.